Shenzhen Chipscreen Biosciences Co. Ltd. Class ASSE: 688321

"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS43158 Tablets

Jul 31, 2026 · Issued by Shenzhen Chipscreen Biosciences Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS43158 Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shenzhen Chipscreen Biosciences Co. Ltd. Class A

"Shenzhen Chipscreen Biosciences Co., Ltd."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of DirectorsJul 27
"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Implementation Result of Shares Repurchase and Share ChangesJul 17
"Shenzhen Chipscreen Biosciences Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026Jul 16
"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Conversion Result of Convertible Bonds and Share ChangesJul 2

All Shenzhen Chipscreen Biosciences Co. Ltd. Class A news releases